Delivery Order SPE2DB22D1202-SPE2DB24FUSL0

Award Date 3/4/24
Potential Completion Date 3/5/24
Potential Value $1.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 36,000 units of the pharmaceutical product CREON DR 100S capsules. The contract has a potential value of $19,565.08 and a completion date of February 29, 2024. Amerisourcebergen Drug Corp serves as the prime contractor and is not operating under any set-aside designation for this award. In addition to this delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, to provide 36,000 units of CREON DR 100S capsules. The contract has a completion date of February 16, 2024 and a potential value of $6,930.91. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 24,000 units of CREON DR 100s capsules. The contract has a potential value of $4,967.24 and a completion date of January 29, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 36,000 units of the pharmaceutical product "CREON DR 36,000 UNIT CAPSULE UU 100S." The contract has a ceiling value of $1,521.38 and a performance period through April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00, which serves as...
The U.S. Defense Logistics Agency (DLA) awarded a $6,042.93 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 36,000 units of CREON DR 36,000 UNIT CAPSULE UU 100S, a pharmaceutical product. The contract has an ultimate completion date of August 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 36,000 unit capsules of the pharmaceutical product CREON DR. The $2,458.62 contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,432.49 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 24,000 unit capsules of the pharmaceutical product CREON DR 100S. The contract has a completion date of February 27, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical and medical supplies to U.S. government agencies, including the Department of...
The U.S. Defense Logistics Agency (DLA) has awarded a $3,163.13 firm-fixed price delivery order (SPE2DB22D1017|SPE2DB24FF7CJ) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 12,000 units of CREON DR 12,000 UNIT CAPSULE UU 100S. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,507.01 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 36,000 unit capsules of the pharmaceutical product CREON DR 100s. The contract has a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order contract is associated with a larger indefinite...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Creon DR 36,000 unit capsules in 100 count packages. The contract award, valued at $2,133.87, has a period of performance through March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and this delivery order is part of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FUSL0
    Delivery Order

The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 36,000 units of CREON DR 4563849287 capsules in 100-count packages. The potential value of this contract is $1,366.89 with a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.

Generated 6/3/24, 9:28 AM